Search details
1.
Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
Biol Blood Marrow Transplant
; 26(1): 157-161, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31521818
2.
Outcomes with Autologous or Allogeneic Stem Cell Transplantation in Patients with Plasma Cell Leukemia in the Era of Novel Agents.
Biol Blood Marrow Transplant
; 26(12): e328-e332, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32961371
3.
Real-world experience with ruxolitinib therapy for steroid-refractory acute graft versus host disease.
Bone Marrow Transplant
; 2024 Feb 24.
Article
in English
| MEDLINE | ID: mdl-38402344
4.
Real-word experience of pazopanib and sorafenib in patients with desmoid tumors: A CanSaRCC multi-center study.
Eur J Cancer
; 205: 114119, 2024 May 14.
Article
in English
| MEDLINE | ID: mdl-38759389
5.
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Curr Oncol
; 31(3): 1426-1444, 2024 03 08.
Article
in English
| MEDLINE | ID: mdl-38534941
6.
Natural resource manager perceptions of agency performance on climate change.
J Environ Manage
; 114: 178-89, 2013 Jan 15.
Article
in English
| MEDLINE | ID: mdl-23141868
7.
An Urgent Call to Integrate the Health Sector into the Post-2020 Global Biodiversity Framework.
Int J Environ Res Public Health
; 20(1)2023 01 03.
Article
in English
| MEDLINE | ID: mdl-36613183
8.
Adherence to CONSORT Guidelines and Reporting of the Determinants of External Validity in Clinical Oncology Randomized Controlled Trials: A Review of Trials Published in Four Major Journals between 2013 and 2015.
Curr Oncol
; 30(2): 2061-2072, 2023 02 08.
Article
in English
| MEDLINE | ID: mdl-36826121
9.
CAR T-Cells for the Treatment of Refractory or Relapsed Large B-Cell Lymphoma: A Single-Center Retrospective Canadian Study.
Clin Lymphoma Myeloma Leuk
; 23(3): 203-210, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36646606
10.
Cost-Effectiveness of Brexucabtagene Autoleucel versus Best Supportive Care for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma following Treatment with a Bruton's Tyrosine Kinase Inhibitor in Canada.
Curr Oncol
; 29(3): 2021-2045, 2022 03 17.
Article
in English
| MEDLINE | ID: mdl-35323364
11.
Changing climate, challenging choices: identifying and evaluating climate change adaptation options for protected areas management in Ontario, Canada.
Environ Manage
; 48(4): 675-90, 2011 Oct.
Article
in English
| MEDLINE | ID: mdl-21850505
12.
Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma.
Bone Marrow Transplant
; 56(11): 2664-2671, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34163014
13.
Outcomes with autologous stem cell transplant vs. non-transplant therapy in patients 70 years and older with multiple myeloma.
Bone Marrow Transplant
; 56(2): 368-375, 2021 02.
Article
in English
| MEDLINE | ID: mdl-32782351
14.
Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.
Leuk Res
; 79: 75-80, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30654975
15.
Tracking human activity and well-being in natural environments using wearable sensors and experience sampling.
Soc Sci Med
; 106: 83-92, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24549253
16.
Canada's uncharted conservation approach.
Science
; 364(6447): 1243, 2019 Jun 28.
Article
in English
| MEDLINE | ID: mdl-31249052
Results
1 -
16
de 16
1
Next >
>>